Newly-released Medical Disposables industry analysis report by Future Market Insights reveals that global sales of medical disposables in 2022 were held at USD 153.5 Billion. With a CAGR of 7.1% from 2023 to 2033, the market is projected to reach a valuation of USD 326.4 Billion by 2033.
Bandages & Wound Dressings is expected to be the highest revenue-generating product type, which is expected to surge at a CAGR of 6.8% from 2023 to 2033.
Attribute | Details |
---|---|
Global Medical Disposables Market (2023) | USD 163.6 Billion |
Global Medical Disposables Market (2033) | USD 326.4 Billion |
Global Medical Disposables Market CAGR (2023 to 2033) | 7.1% |
USA Medical Disposables Market CAGR (2023 to 2033) | 6.9% |
Key Companies Profiled | Medline Industries, Inc.; Smith & Nephew PLC; Bayer AG; Becton Dickinson and Company; 3M; Cardinal Health; Johnson & Johnson; Abbott; Medtronic; B Braun Melsungen AG |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Medical Disposables industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at around 6.3% CAGR, wherein, countries such as the USA, China, Japan, United kingdom, and South Korea held a significant share in the global market.
Medical disposables are disposable materials including gloves, robes, and face masks used by medical workers to protect their hands from contamination and illness when they come in contact with a patient.
Medical disposables have been used since the early 1800s when they were constructed of cotton wool, lint bandages, and paper dressings that did not protect the wearer from chemical or biological agents. New material has been produced throughout time that is not only more effective in terms of protection but also less expensive, to fulfill the demands of all healthcare facilities, large and small.
The rising incidence of Hospital Acquired Infections, an increasing number of surgical procedures, and the growing prevalence of chronic diseases leading to longer hospital admission have been the key factors driving the market. Owing to these factors, the medical disposables market is projected to grow at a CAGR of 7.1% over the coming 10 years.
The subsequent spike in the number of chronic illness cases and a rise in the rate of hospitalizations has fueled the field of emergency medical disposables growth. The expansion of the medical disposables market is being fueled by an increase in the prevalence of hospital-acquired illnesses and disorders, as well as a greater focus on infection prevention.
For example, the prevalence of healthcare-associated infection in high-income countries ranges from 3.5% to 12%, whereas it ranges from 5.7% to 19.1% in low and medium-income countries.
A growing geriatric population, an increase in the incidence of incontinence issues, mandatory guidelines that must be followed for patient safety at healthcare institutions, and an increase in demand for sophisticated healthcare facilities is driving the medical disposables market.
The market in North America is expected to reach a valuation of USD 131 Billion by 2033 from USD 61.7 Billion in 2022. In August 2000, the Food and Drug Administration (FDA) issued guidance concerning healthcare single-use items reprocessed by third parties or hospitals. In this guidance, FDA stated that hospitals or third-party reprocessors would be considered manufacturers and regulated in the exact same manner.
A newly used single-use device still has to fulfill the criteria for device activation required by its flagship when it was originally manufactured. Such regulations have been creating a positive impact on the medical disposables market in the USA market in specific and the North American market in general.
Medical Disposables Market in the USA is expected to gross an absolute dollar opportunity of USD 55.3 Billion by 2033. Due to the rising number of surgeries and the presence of key players in the country, the USA accounts for a significant opportunity in the global market. A rise in the number of COVID-19 patients in the country has boosted the demand for medical supplies.
The market in the United kingdom is expected to reach a valuation of USD 16.5 Billion by 2033. Growing with a CAGR of 6.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around USD 7.5 Billion.
In Japan, the market is expected to grow at a CAGR of 5.7% from 2023 to 2033, reaching around USD 16.8 Billion by 2033. The market in the country is expected to gross an absolute dollar opportunity of USD 7.1 Billion during the forecast period.
The market in South Korea is expected to reach a valuation of around USD 15 Billion by 2033, growing at a CAGR of 5.1% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around USD 5.9 Billion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Plastic resin-based medical disposables are expected to have a significant market share and is expected to grow at a CAGR of 6.4% during the forecast period. Plastic resins led the market in terms of raw materials, accounting for more than 55% of total revenue in 2022. Medical equipment such as containers, disposable syringes, tubes for intravenous solutions, and various packaging materials for pharmaceuticals are made with plastic resins.
The market is developing due to the rising occurrence of hospital-acquired illnesses and the resulting increased use of disposable goods to minimize the transmission of COVID-19. The availability of many types of plastics with a wide variety of qualities, such as PVC, PP, low and high-density polyethylene, and polystyrene, has broadened the uses of plastics in the healthcare industry.
The key companies in the market are engaged in mergers, acquisitions and partnerships.
The key players in the market include 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health.
Some of the recent developments of key Medical Disposables providers are as follows:
Similarly, recent developments related to companies offering Medical Disposables have been tracked by the team at Future Market Insights, which are available in the full report.
The market is valued at USD 163.6 billion in 2023.
The market is expected to record a CAGR of 7.1% through 2033.
Germany is expected to expand at a CAGR of 5.1% from 2023 to 2033.
Plastic resin is poised to stay attractive, projecting a CAGR of 6.4% through 2033.
Medline Industries, Inc., Smith & Nephew PLC, and Bayer AG are key market players.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Surgical Instruments & Supplies 5.1.1. Would Closures 5.1.2. Procedural Kits & Trays 5.1.3. Surgical Catheters 5.1.4. Surgical Instruments 5.1.5. Plastic Surgical Drapes 5.2. Infusion and Hypodermic Devices 5.2.1. Infusion Devices 5.2.2. Hypodermic Devices 5.3. Diagnostic & Laboratory Disposables 5.3.1. Home Testing Supplies 5.3.2. Blood Collection Sets 5.3.3. Disposable Labware 5.3.4. Others 5.4. Bandages and Wound Dressings 5.4.1. Gowns 5.4.2. Drapes 5.4.3. Face Masks 5.4.4. Others 5.5. Sterilization Supplies 5.5.1. Sterile Containers 5.5.2. Sterilization Wraps 5.5.3. Sterilization Indicators 5.6. Respiratory Devices 5.6.1. Prefilled Inhalers 5.6.2. Oxygen Delivery Systems 5.6.3. Anesthesia Disposables 5.6.4. Others 5.7. Dialysis Disposables 5.7.1. Hemodialysis Products 5.7.2. Peritoneal Dialysis Products 5.8. Medical & Laboratory Gloves 5.8.1. Examination Gloves 5.8.2. Surgical Gloves 5.8.3. Laboratory Gloves 5.8.4. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Raw Materials 6.1. Plastic Resins 6.2. Nonwoven Material 6.3. Rubber 6.4. Metal 6.5. Glass 6.6. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Home Healthcare 7.3. Outpatient/Primary Care Facilities 7.4. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Abbott Laboratories 16.2. 3M 16.3. Bayer 16.4. Becton, Dickinson and Company 16.5. Pfizer 16.6. Boston Scientific 16.7. Medtronic Plc 16.8. Johnson and Johnson 16.9. Smith and Nephew 16.10. Cardinal Health 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports